Our study included the first sample of deceased patients with 4R-tauopathies and disease controls, which allowed us to establish a PET-to-autopsy correlation between in vivo [18F]PI-2620 signals and the quantitative tau load ex vivo. The gene discussed is MAPT; the disease is tauopathy.